Literature DB >> 30711375

A Code of Mono-phosphorylation Modulates the Function of RB.

Ioannis Sanidas1, Robert Morris1, Katerina A Fella1, Purva H Rumde1, Myriam Boukhali1, Eric C Tai1, David T Ting1, Michael S Lawrence2, Wilhelm Haas1, Nicholas J Dyson3.   

Abstract

Hyper-phosphorylation of RB controls its interaction with E2F and inhibits its tumor suppressor properties. However, during G1 active RB can be mono-phosphorylated on any one of 14 CDK phosphorylation sites. Here, we used quantitative proteomics to profile protein complexes formed by each mono-phosphorylated RB isoform (mP-RB) and identified the associated transcriptional outputs. The results show that the 14 sites of mono-phosphorylation co-ordinate RB's interactions and confer functional specificity. All 14 mP-RBs interact with E2F/DP proteins, but they provide different shades of E2F regulation. RB mono-phosphorylation at S811, for example, alters RB transcriptional activity by promoting its association with NuRD complexes. The greatest functional differences between mP-RBs are evident beyond the cell cycle machinery. RB mono-phosphorylation at S811 or T826 stimulates the expression of oxidative phosphorylation genes, increasing cellular oxygen consumption. These results indicate that RB activation signals are integrated in a phosphorylation code that determines the diversity of RB activity.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30711375      PMCID: PMC6424368          DOI: 10.1016/j.molcel.2019.01.004

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  72 in total

Review 1.  Retinoblastoma protein partners.

Authors:  E J Morris; N J Dyson
Journal:  Adv Cancer Res       Date:  2001       Impact factor: 6.242

2.  Mdm2-mediated pRB downregulation is involved in carcinogenesis in a p53-independent manner.

Authors:  Seiichi Miwa; Chiharu Uchida; Kyoko Kitagawa; Takayuki Hattori; Toshiaki Oda; Haruhiko Sugimura; Hideyo Yasuda; Hirotoshi Nakamura; Kingo Chida; Masatoshi Kitagawa
Journal:  Biochem Biophys Res Commun       Date:  2005-12-06       Impact factor: 3.575

3.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.

Authors:  Joshua E Elias; Steven P Gygi
Journal:  Nat Methods       Date:  2007-03       Impact factor: 28.547

4.  RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

Authors:  Hyun-Soo Cho; Shinya Hayami; Gouji Toyokawa; Kazuhiro Maejima; Yuka Yamane; Takehiro Suzuki; Naoshi Dohmae; Masaharu Kogure; Daechun Kang; David E Neal; Bruce A J Ponder; Hiroki Yamaue; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

5.  The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo.

Authors:  Kristen L Meerbrey; Guang Hu; Jessica D Kessler; Kevin Roarty; Mamie Z Li; Justin E Fang; Jason I Herschkowitz; Anna E Burrows; Alberto Ciccia; Tingting Sun; Earlene M Schmitt; Ronald J Bernardi; Xiaoyong Fu; Christopher S Bland; Thomas A Cooper; Rachel Schiff; Jeffrey M Rosen; Thomas F Westbrook; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-09       Impact factor: 11.205

Review 6.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

7.  Interaction of the retinoblastoma protein with Orc1 and its recruitment to human origins of DNA replication.

Authors:  Ramiro Mendoza-Maldonado; Roberta Paolinelli; Laura Galbiati; Sara Giadrossi; Mauro Giacca
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

8.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 9.  Non-canonical functions of the RB protein in cancer.

Authors:  Frederick A Dick; David W Goodrich; Julien Sage; Nicholas J Dyson
Journal:  Nat Rev Cancer       Date:  2018-07       Impact factor: 60.716

10.  DNA-damage-responsive acetylation of pRb regulates binding to E2F-1.

Authors:  Douglas Markham; Shonagh Munro; Judith Soloway; Darran P O'Connor; Nicholas B La Thangue
Journal:  EMBO Rep       Date:  2006-02       Impact factor: 8.807

View more
  34 in total

Review 1.  Preparation for DNA replication: the key to a successful S phase.

Authors:  Juanita C Limas; Jeanette Gowen Cook
Journal:  FEBS Lett       Date:  2019-10-15       Impact factor: 4.124

Review 2.  Bistable switches as integrators and actuators during cell cycle progression.

Authors:  Wayne Stallaert; Katarzyna M Kedziora; Hui Xiao Chao; Jeremy E Purvis
Journal:  FEBS Lett       Date:  2019-10-16       Impact factor: 4.124

3.  The structure of the human cell cycle.

Authors:  Wayne Stallaert; Katarzyna M Kedziora; Colin D Taylor; Tarek M Zikry; Jolene S Ranek; Holly K Sobon; Sovanny R Taylor; Catherine L Young; Jeanette G Cook; Jeremy E Purvis
Journal:  Cell Syst       Date:  2021-11-19       Impact factor: 10.304

4.  Chromatin-bound RB targets promoters, enhancers, and CTCF-bound loci and is redistributed by cell-cycle progression.

Authors:  Ioannis Sanidas; Hanjun Lee; Purva H Rumde; Gaylor Boulay; Robert Morris; Gabriel Golczer; Marcelo Stanzione; Soroush Hajizadeh; Jun Zhong; Meagan B Ryan; Ryan B Corcoran; Benjamin J Drapkin; Miguel N Rivera; Nicholas J Dyson; Michael S Lawrence
Journal:  Mol Cell       Date:  2022-08-17       Impact factor: 19.328

5.  Structural basis for tunable affinity and specificity of LxCxE-dependent protein interactions with the retinoblastoma protein family.

Authors:  Sivasankar Putta; Lucia Alvarez; Stephan Lüdtke; Peter Sehr; Gerd A Müller; Samantha M Fernandez; Sarvind Tripathi; Joe Lewis; Toby J Gibson; Lucia B Chemes; Seth M Rubin
Journal:  Structure       Date:  2022-06-17       Impact factor: 5.871

Review 6.  Cancer cell cycle dystopia: heterogeneity, plasticity, and therapy.

Authors:  Agnieszka K Witkiewicz; Vishnu Kumarasamy; Ioannis Sanidas; Erik S Knudsen
Journal:  Trends Cancer       Date:  2022-05-20

Review 7.  Post-translational modifications on the retinoblastoma protein.

Authors:  Linbin Zhou; Danny Siu-Chun Ng; Jason C Yam; Li Jia Chen; Clement C Tham; Chi Pui Pang; Wai Kit Chu
Journal:  J Biomed Sci       Date:  2022-06-01       Impact factor: 12.771

8.  p21 produces a bioactive secretome that places stressed cells under immunosurveillance.

Authors:  Ines Sturmlechner; Cheng Zhang; Chance C Sine; Erik-Jan van Deursen; Karthik B Jeganathan; Naomi Hamada; Jan Grasic; David Friedman; Jeremy T Stutchman; Ismail Can; Masakazu Hamada; Do Young Lim; Jeong-Heon Lee; Tamas Ordog; Remi-Martin Laberge; Virginia Shapiro; Darren J Baker; Hu Li; Jan M van Deursen
Journal:  Science       Date:  2021-10-29       Impact factor: 63.714

9.  Co-expression patterns explain how a basic transcriptional role for MYC modulates Wnt and MAPK pathways in colon and lung adenocarcinomas.

Authors:  Melanie Haas Kucherlapati
Journal:  Cell Cycle       Date:  2022-04-19       Impact factor: 5.173

Review 10.  Cell cycle control in cancer.

Authors:  Helen K Matthews; Cosetta Bertoli; Robertus A M de Bruin
Journal:  Nat Rev Mol Cell Biol       Date:  2021-09-10       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.